Frontiers in Molecular Biosciences-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2214974, encodeId=513922149e416, content=偏重的研究方向：心血管 经验分享：7月2日刚提交，生信加实验验证，第二天就Independent Review，这个是好事还是坏事，显示一个REVIEW is going？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Mon Jul 15 09:28:21 CST 2024, time=2024-07-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1063736, encodeId=74e11063e36b7, content=审稿周期大概多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Oct 25 11:50:38 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225890, encodeId=82d41225890ba, content=影响因子是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4a655416689, createdName=ms4000001314716194, createdTime=Sat Jun 11 22:25:05 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119003, encodeId=1f3d211900309, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：Cancer 经验分享：今年安全了，刚中了一篇综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Sat Mar 11 23:51:10 CST 2023, time=2023-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1076702, encodeId=9bc810e670206, content=审稿速度:4.0 | 投稿命中率:50.0 经验分享：Initial validation阶段被拒，生信+实验验证我自己中了两篇6、7分的生信根据最近这个杂志发表的论文和我收到的几份这个杂志邀请审稿的生信论文水平。新颖度和工作量应该是绰绰有余，然而在initial阶段被拒，认为不符合杂志出版要求。感觉很迷。以上供参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1265488636, createdName=Chiah, createdTime=Sat Dec 04 02:41:56 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239681, encodeId=ad19123968114, content=中科院预警了还能投么？会报销版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a02382367, createdName=123170bfm97(暂无昵称), createdTime=Fri Aug 19 10:23:37 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221463, encodeId=7b6e1221463ef, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:32 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085410, encodeId=46a01085410af, content=投稿近一个月，依旧initial validation.有遇到相同问题的吗，求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Wed Dec 29 12:36:43 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973575, encodeId=aae99e3575bb, content=我2021-04-28submission.然后要我上传原始数据，我五月四号上传了，然后一直在initial validation，没有消息，给编辑邮件是在6月1号，然后6月7号收到回复，进入editorial assignment,状态显示是没有找到assistant editor.有没有被拖了很久的前辈建议一下，撤稿还是不撤！等着毕业啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2705491352, createdName=ms1000000763087424, createdTime=Mon Jun 14 22:16:48 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083916, encodeId=06591083916a7, content=投稿20天依旧initial validation., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Fri Dec 24 14:41:04 CST 2021, time=2021-12-24, status=1, ipAttribution=)]

2024-07-15 ms5000001250467069 来自江西省

偏重的研究方向：心血管
经验分享：7月2日刚提交，生信加实验验证，第二天就Independent Review，这个是好事还是坏事，显示一个REVIEW is going？

90 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2214974, encodeId=513922149e416, content=偏重的研究方向：心血管 经验分享：7月2日刚提交，生信加实验验证，第二天就Independent Review，这个是好事还是坏事，显示一个REVIEW is going？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Mon Jul 15 09:28:21 CST 2024, time=2024-07-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1063736, encodeId=74e11063e36b7, content=审稿周期大概多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Oct 25 11:50:38 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225890, encodeId=82d41225890ba, content=影响因子是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4a655416689, createdName=ms4000001314716194, createdTime=Sat Jun 11 22:25:05 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119003, encodeId=1f3d211900309, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：Cancer 经验分享：今年安全了，刚中了一篇综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Sat Mar 11 23:51:10 CST 2023, time=2023-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1076702, encodeId=9bc810e670206, content=审稿速度:4.0 | 投稿命中率:50.0 经验分享：Initial validation阶段被拒，生信+实验验证我自己中了两篇6、7分的生信根据最近这个杂志发表的论文和我收到的几份这个杂志邀请审稿的生信论文水平。新颖度和工作量应该是绰绰有余，然而在initial阶段被拒，认为不符合杂志出版要求。感觉很迷。以上供参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1265488636, createdName=Chiah, createdTime=Sat Dec 04 02:41:56 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239681, encodeId=ad19123968114, content=中科院预警了还能投么？会报销版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a02382367, createdName=123170bfm97(暂无昵称), createdTime=Fri Aug 19 10:23:37 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221463, encodeId=7b6e1221463ef, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:32 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085410, encodeId=46a01085410af, content=投稿近一个月，依旧initial validation.有遇到相同问题的吗，求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Wed Dec 29 12:36:43 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973575, encodeId=aae99e3575bb, content=我2021-04-28submission.然后要我上传原始数据，我五月四号上传了，然后一直在initial validation，没有消息，给编辑邮件是在6月1号，然后6月7号收到回复，进入editorial assignment,状态显示是没有找到assistant editor.有没有被拖了很久的前辈建议一下，撤稿还是不撤！等着毕业啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2705491352, createdName=ms1000000763087424, createdTime=Mon Jun 14 22:16:48 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083916, encodeId=06591083916a7, content=投稿20天依旧initial validation., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Fri Dec 24 14:41:04 CST 2021, time=2021-12-24, status=1, ipAttribution=)]

2021-10-25 mswert122

审稿周期大概多久？

111 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2214974, encodeId=513922149e416, content=偏重的研究方向：心血管 经验分享：7月2日刚提交，生信加实验验证，第二天就Independent Review，这个是好事还是坏事，显示一个REVIEW is going？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Mon Jul 15 09:28:21 CST 2024, time=2024-07-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1063736, encodeId=74e11063e36b7, content=审稿周期大概多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Oct 25 11:50:38 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225890, encodeId=82d41225890ba, content=影响因子是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4a655416689, createdName=ms4000001314716194, createdTime=Sat Jun 11 22:25:05 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119003, encodeId=1f3d211900309, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：Cancer 经验分享：今年安全了，刚中了一篇综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Sat Mar 11 23:51:10 CST 2023, time=2023-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1076702, encodeId=9bc810e670206, content=审稿速度:4.0 | 投稿命中率:50.0 经验分享：Initial validation阶段被拒，生信+实验验证我自己中了两篇6、7分的生信根据最近这个杂志发表的论文和我收到的几份这个杂志邀请审稿的生信论文水平。新颖度和工作量应该是绰绰有余，然而在initial阶段被拒，认为不符合杂志出版要求。感觉很迷。以上供参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1265488636, createdName=Chiah, createdTime=Sat Dec 04 02:41:56 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239681, encodeId=ad19123968114, content=中科院预警了还能投么？会报销版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a02382367, createdName=123170bfm97(暂无昵称), createdTime=Fri Aug 19 10:23:37 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221463, encodeId=7b6e1221463ef, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:32 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085410, encodeId=46a01085410af, content=投稿近一个月，依旧initial validation.有遇到相同问题的吗，求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Wed Dec 29 12:36:43 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973575, encodeId=aae99e3575bb, content=我2021-04-28submission.然后要我上传原始数据，我五月四号上传了，然后一直在initial validation，没有消息，给编辑邮件是在6月1号，然后6月7号收到回复，进入editorial assignment,状态显示是没有找到assistant editor.有没有被拖了很久的前辈建议一下，撤稿还是不撤！等着毕业啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2705491352, createdName=ms1000000763087424, createdTime=Mon Jun 14 22:16:48 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083916, encodeId=06591083916a7, content=投稿20天依旧initial validation., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Fri Dec 24 14:41:04 CST 2021, time=2021-12-24, status=1, ipAttribution=)]

2022-06-11 ms4000001314716194

影响因子是多少啊

148 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2214974, encodeId=513922149e416, content=偏重的研究方向：心血管 经验分享：7月2日刚提交，生信加实验验证，第二天就Independent Review，这个是好事还是坏事，显示一个REVIEW is going？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Mon Jul 15 09:28:21 CST 2024, time=2024-07-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1063736, encodeId=74e11063e36b7, content=审稿周期大概多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Oct 25 11:50:38 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225890, encodeId=82d41225890ba, content=影响因子是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4a655416689, createdName=ms4000001314716194, createdTime=Sat Jun 11 22:25:05 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119003, encodeId=1f3d211900309, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：Cancer 经验分享：今年安全了，刚中了一篇综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Sat Mar 11 23:51:10 CST 2023, time=2023-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1076702, encodeId=9bc810e670206, content=审稿速度:4.0 | 投稿命中率:50.0 经验分享：Initial validation阶段被拒，生信+实验验证我自己中了两篇6、7分的生信根据最近这个杂志发表的论文和我收到的几份这个杂志邀请审稿的生信论文水平。新颖度和工作量应该是绰绰有余，然而在initial阶段被拒，认为不符合杂志出版要求。感觉很迷。以上供参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1265488636, createdName=Chiah, createdTime=Sat Dec 04 02:41:56 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239681, encodeId=ad19123968114, content=中科院预警了还能投么？会报销版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a02382367, createdName=123170bfm97(暂无昵称), createdTime=Fri Aug 19 10:23:37 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221463, encodeId=7b6e1221463ef, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:32 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085410, encodeId=46a01085410af, content=投稿近一个月，依旧initial validation.有遇到相同问题的吗，求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Wed Dec 29 12:36:43 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973575, encodeId=aae99e3575bb, content=我2021-04-28submission.然后要我上传原始数据，我五月四号上传了，然后一直在initial validation，没有消息，给编辑邮件是在6月1号，然后6月7号收到回复，进入editorial assignment,状态显示是没有找到assistant editor.有没有被拖了很久的前辈建议一下，撤稿还是不撤！等着毕业啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2705491352, createdName=ms1000000763087424, createdTime=Mon Jun 14 22:16:48 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083916, encodeId=06591083916a7, content=投稿20天依旧initial validation., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Fri Dec 24 14:41:04 CST 2021, time=2021-12-24, status=1, ipAttribution=)]

2023-03-11 CH常来自北京

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：Cancer
经验分享：今年安全了，刚中了一篇综述

110 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2214974, encodeId=513922149e416, content=偏重的研究方向：心血管 经验分享：7月2日刚提交，生信加实验验证，第二天就Independent Review，这个是好事还是坏事，显示一个REVIEW is going？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Mon Jul 15 09:28:21 CST 2024, time=2024-07-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1063736, encodeId=74e11063e36b7, content=审稿周期大概多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Oct 25 11:50:38 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225890, encodeId=82d41225890ba, content=影响因子是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4a655416689, createdName=ms4000001314716194, createdTime=Sat Jun 11 22:25:05 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119003, encodeId=1f3d211900309, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：Cancer 经验分享：今年安全了，刚中了一篇综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Sat Mar 11 23:51:10 CST 2023, time=2023-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1076702, encodeId=9bc810e670206, content=审稿速度:4.0 | 投稿命中率:50.0 经验分享：Initial validation阶段被拒，生信+实验验证我自己中了两篇6、7分的生信根据最近这个杂志发表的论文和我收到的几份这个杂志邀请审稿的生信论文水平。新颖度和工作量应该是绰绰有余，然而在initial阶段被拒，认为不符合杂志出版要求。感觉很迷。以上供参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1265488636, createdName=Chiah, createdTime=Sat Dec 04 02:41:56 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239681, encodeId=ad19123968114, content=中科院预警了还能投么？会报销版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a02382367, createdName=123170bfm97(暂无昵称), createdTime=Fri Aug 19 10:23:37 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221463, encodeId=7b6e1221463ef, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:32 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085410, encodeId=46a01085410af, content=投稿近一个月，依旧initial validation.有遇到相同问题的吗，求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Wed Dec 29 12:36:43 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973575, encodeId=aae99e3575bb, content=我2021-04-28submission.然后要我上传原始数据，我五月四号上传了，然后一直在initial validation，没有消息，给编辑邮件是在6月1号，然后6月7号收到回复，进入editorial assignment,状态显示是没有找到assistant editor.有没有被拖了很久的前辈建议一下，撤稿还是不撤！等着毕业啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2705491352, createdName=ms1000000763087424, createdTime=Mon Jun 14 22:16:48 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083916, encodeId=06591083916a7, content=投稿20天依旧initial validation., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Fri Dec 24 14:41:04 CST 2021, time=2021-12-24, status=1, ipAttribution=)]

2021-12-04 Chiah

审稿速度:4.0 | 投稿命中率:50.0
经验分享：Initial validation阶段被拒，生信+实验验证我自己中了两篇6、7分的生信根据最近这个杂志发表的论文和我收到的几份这个杂志邀请审稿的生信论文水平。新颖度和工作量应该是绰绰有余，然而在initial阶段被拒，认为不符合杂志出版要求。感觉很迷。以上供参考

169 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2214974, encodeId=513922149e416, content=偏重的研究方向：心血管 经验分享：7月2日刚提交，生信加实验验证，第二天就Independent Review，这个是好事还是坏事，显示一个REVIEW is going？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Mon Jul 15 09:28:21 CST 2024, time=2024-07-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1063736, encodeId=74e11063e36b7, content=审稿周期大概多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Oct 25 11:50:38 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225890, encodeId=82d41225890ba, content=影响因子是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4a655416689, createdName=ms4000001314716194, createdTime=Sat Jun 11 22:25:05 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119003, encodeId=1f3d211900309, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：Cancer 经验分享：今年安全了，刚中了一篇综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Sat Mar 11 23:51:10 CST 2023, time=2023-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1076702, encodeId=9bc810e670206, content=审稿速度:4.0 | 投稿命中率:50.0 经验分享：Initial validation阶段被拒，生信+实验验证我自己中了两篇6、7分的生信根据最近这个杂志发表的论文和我收到的几份这个杂志邀请审稿的生信论文水平。新颖度和工作量应该是绰绰有余，然而在initial阶段被拒，认为不符合杂志出版要求。感觉很迷。以上供参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1265488636, createdName=Chiah, createdTime=Sat Dec 04 02:41:56 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239681, encodeId=ad19123968114, content=中科院预警了还能投么？会报销版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a02382367, createdName=123170bfm97(暂无昵称), createdTime=Fri Aug 19 10:23:37 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221463, encodeId=7b6e1221463ef, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:32 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085410, encodeId=46a01085410af, content=投稿近一个月，依旧initial validation.有遇到相同问题的吗，求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Wed Dec 29 12:36:43 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973575, encodeId=aae99e3575bb, content=我2021-04-28submission.然后要我上传原始数据，我五月四号上传了，然后一直在initial validation，没有消息，给编辑邮件是在6月1号，然后6月7号收到回复，进入editorial assignment,状态显示是没有找到assistant editor.有没有被拖了很久的前辈建议一下，撤稿还是不撤！等着毕业啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2705491352, createdName=ms1000000763087424, createdTime=Mon Jun 14 22:16:48 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083916, encodeId=06591083916a7, content=投稿20天依旧initial validation., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Fri Dec 24 14:41:04 CST 2021, time=2021-12-24, status=1, ipAttribution=)]

2022-08-19 123170bfm97(暂无昵称)

中科院预警了还能投么？会报销版面费么？

173 0

[GetPortalCommentsPageByObjectIdResponse(id=2214974, encodeId=513922149e416, content=偏重的研究方向：心血管 经验分享：7月2日刚提交，生信加实验验证，第二天就Independent Review，这个是好事还是坏事，显示一个REVIEW is going？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Mon Jul 15 09:28:21 CST 2024, time=2024-07-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1063736, encodeId=74e11063e36b7, content=审稿周期大概多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Oct 25 11:50:38 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225890, encodeId=82d41225890ba, content=影响因子是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4a655416689, createdName=ms4000001314716194, createdTime=Sat Jun 11 22:25:05 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119003, encodeId=1f3d211900309, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：Cancer 经验分享：今年安全了，刚中了一篇综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Sat Mar 11 23:51:10 CST 2023, time=2023-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1076702, encodeId=9bc810e670206, content=审稿速度:4.0 | 投稿命中率:50.0 经验分享：Initial validation阶段被拒，生信+实验验证我自己中了两篇6、7分的生信根据最近这个杂志发表的论文和我收到的几份这个杂志邀请审稿的生信论文水平。新颖度和工作量应该是绰绰有余，然而在initial阶段被拒，认为不符合杂志出版要求。感觉很迷。以上供参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1265488636, createdName=Chiah, createdTime=Sat Dec 04 02:41:56 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239681, encodeId=ad19123968114, content=中科院预警了还能投么？会报销版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a02382367, createdName=123170bfm97(暂无昵称), createdTime=Fri Aug 19 10:23:37 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221463, encodeId=7b6e1221463ef, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:32 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085410, encodeId=46a01085410af, content=投稿近一个月，依旧initial validation.有遇到相同问题的吗，求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Wed Dec 29 12:36:43 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973575, encodeId=aae99e3575bb, content=我2021-04-28submission.然后要我上传原始数据，我五月四号上传了，然后一直在initial validation，没有消息，给编辑邮件是在6月1号，然后6月7号收到回复，进入editorial assignment,状态显示是没有找到assistant editor.有没有被拖了很久的前辈建议一下，撤稿还是不撤！等着毕业啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2705491352, createdName=ms1000000763087424, createdTime=Mon Jun 14 22:16:48 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083916, encodeId=06591083916a7, content=投稿20天依旧initial validation., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Fri Dec 24 14:41:04 CST 2021, time=2021-12-24, status=1, ipAttribution=)]

2022-05-21 peach_adore

mark

198 0

[GetPortalCommentsPageByObjectIdResponse(id=2214974, encodeId=513922149e416, content=偏重的研究方向：心血管 经验分享：7月2日刚提交，生信加实验验证，第二天就Independent Review，这个是好事还是坏事，显示一个REVIEW is going？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Mon Jul 15 09:28:21 CST 2024, time=2024-07-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1063736, encodeId=74e11063e36b7, content=审稿周期大概多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Oct 25 11:50:38 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225890, encodeId=82d41225890ba, content=影响因子是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4a655416689, createdName=ms4000001314716194, createdTime=Sat Jun 11 22:25:05 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119003, encodeId=1f3d211900309, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：Cancer 经验分享：今年安全了，刚中了一篇综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Sat Mar 11 23:51:10 CST 2023, time=2023-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1076702, encodeId=9bc810e670206, content=审稿速度:4.0 | 投稿命中率:50.0 经验分享：Initial validation阶段被拒，生信+实验验证我自己中了两篇6、7分的生信根据最近这个杂志发表的论文和我收到的几份这个杂志邀请审稿的生信论文水平。新颖度和工作量应该是绰绰有余，然而在initial阶段被拒，认为不符合杂志出版要求。感觉很迷。以上供参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1265488636, createdName=Chiah, createdTime=Sat Dec 04 02:41:56 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239681, encodeId=ad19123968114, content=中科院预警了还能投么？会报销版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a02382367, createdName=123170bfm97(暂无昵称), createdTime=Fri Aug 19 10:23:37 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221463, encodeId=7b6e1221463ef, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:32 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085410, encodeId=46a01085410af, content=投稿近一个月，依旧initial validation.有遇到相同问题的吗，求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Wed Dec 29 12:36:43 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973575, encodeId=aae99e3575bb, content=我2021-04-28submission.然后要我上传原始数据，我五月四号上传了，然后一直在initial validation，没有消息，给编辑邮件是在6月1号，然后6月7号收到回复，进入editorial assignment,状态显示是没有找到assistant editor.有没有被拖了很久的前辈建议一下，撤稿还是不撤！等着毕业啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2705491352, createdName=ms1000000763087424, createdTime=Mon Jun 14 22:16:48 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083916, encodeId=06591083916a7, content=投稿20天依旧initial validation., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Fri Dec 24 14:41:04 CST 2021, time=2021-12-24, status=1, ipAttribution=)]

2021-12-29 鸭嘴兽花

投稿近一个月，依旧initial validation.有遇到相同问题的吗，求指点

157 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2214974, encodeId=513922149e416, content=偏重的研究方向：心血管 经验分享：7月2日刚提交，生信加实验验证，第二天就Independent Review，这个是好事还是坏事，显示一个REVIEW is going？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Mon Jul 15 09:28:21 CST 2024, time=2024-07-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1063736, encodeId=74e11063e36b7, content=审稿周期大概多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Oct 25 11:50:38 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225890, encodeId=82d41225890ba, content=影响因子是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4a655416689, createdName=ms4000001314716194, createdTime=Sat Jun 11 22:25:05 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119003, encodeId=1f3d211900309, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：Cancer 经验分享：今年安全了，刚中了一篇综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Sat Mar 11 23:51:10 CST 2023, time=2023-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1076702, encodeId=9bc810e670206, content=审稿速度:4.0 | 投稿命中率:50.0 经验分享：Initial validation阶段被拒，生信+实验验证我自己中了两篇6、7分的生信根据最近这个杂志发表的论文和我收到的几份这个杂志邀请审稿的生信论文水平。新颖度和工作量应该是绰绰有余，然而在initial阶段被拒，认为不符合杂志出版要求。感觉很迷。以上供参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1265488636, createdName=Chiah, createdTime=Sat Dec 04 02:41:56 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239681, encodeId=ad19123968114, content=中科院预警了还能投么？会报销版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a02382367, createdName=123170bfm97(暂无昵称), createdTime=Fri Aug 19 10:23:37 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221463, encodeId=7b6e1221463ef, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:32 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085410, encodeId=46a01085410af, content=投稿近一个月，依旧initial validation.有遇到相同问题的吗，求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Wed Dec 29 12:36:43 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973575, encodeId=aae99e3575bb, content=我2021-04-28submission.然后要我上传原始数据，我五月四号上传了，然后一直在initial validation，没有消息，给编辑邮件是在6月1号，然后6月7号收到回复，进入editorial assignment,状态显示是没有找到assistant editor.有没有被拖了很久的前辈建议一下，撤稿还是不撤！等着毕业啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2705491352, createdName=ms1000000763087424, createdTime=Mon Jun 14 22:16:48 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083916, encodeId=06591083916a7, content=投稿20天依旧initial validation., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Fri Dec 24 14:41:04 CST 2021, time=2021-12-24, status=1, ipAttribution=)]

2021-06-14 ms1000000763087424

我2021-04-28submission.然后要我上传原始数据，我五月四号上传了，然后一直在initial validation，没有消息，给编辑邮件是在6月1号，然后6月7号收到回复，进入editorial assignment,状态显示是没有找到assistant editor.有没有被拖了很久的前辈建议一下，撤稿还是不撤！等着毕业啊！

156 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2214974, encodeId=513922149e416, content=偏重的研究方向：心血管 经验分享：7月2日刚提交，生信加实验验证，第二天就Independent Review，这个是好事还是坏事，显示一个REVIEW is going？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Mon Jul 15 09:28:21 CST 2024, time=2024-07-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1063736, encodeId=74e11063e36b7, content=审稿周期大概多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Oct 25 11:50:38 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225890, encodeId=82d41225890ba, content=影响因子是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4a655416689, createdName=ms4000001314716194, createdTime=Sat Jun 11 22:25:05 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119003, encodeId=1f3d211900309, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：Cancer 经验分享：今年安全了，刚中了一篇综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Sat Mar 11 23:51:10 CST 2023, time=2023-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1076702, encodeId=9bc810e670206, content=审稿速度:4.0 | 投稿命中率:50.0 经验分享：Initial validation阶段被拒，生信+实验验证我自己中了两篇6、7分的生信根据最近这个杂志发表的论文和我收到的几份这个杂志邀请审稿的生信论文水平。新颖度和工作量应该是绰绰有余，然而在initial阶段被拒，认为不符合杂志出版要求。感觉很迷。以上供参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1265488636, createdName=Chiah, createdTime=Sat Dec 04 02:41:56 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239681, encodeId=ad19123968114, content=中科院预警了还能投么？会报销版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a02382367, createdName=123170bfm97(暂无昵称), createdTime=Fri Aug 19 10:23:37 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221463, encodeId=7b6e1221463ef, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:32 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085410, encodeId=46a01085410af, content=投稿近一个月，依旧initial validation.有遇到相同问题的吗，求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Wed Dec 29 12:36:43 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973575, encodeId=aae99e3575bb, content=我2021-04-28submission.然后要我上传原始数据，我五月四号上传了，然后一直在initial validation，没有消息，给编辑邮件是在6月1号，然后6月7号收到回复，进入editorial assignment,状态显示是没有找到assistant editor.有没有被拖了很久的前辈建议一下，撤稿还是不撤！等着毕业啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2705491352, createdName=ms1000000763087424, createdTime=Mon Jun 14 22:16:48 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083916, encodeId=06591083916a7, content=投稿20天依旧initial validation., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Fri Dec 24 14:41:04 CST 2021, time=2021-12-24, status=1, ipAttribution=)]

2021-12-24 鸭嘴兽花

投稿20天依旧initial validation.

177 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务